HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Randomized, double-blind, placebo-controlled study of Malarone for malaria prophylaxis in non-immune Colombian soldiers.

Abstract
Malarone was compared with placebo in a double-blind, randomized, placebo-controlled trial of prophylaxis of malaria in predominately Plasmodium vivax areas of Colombia. The study population consisted of 180 completely non-immune Colombian soldiers, male, average age 19 years, and average weight 63 kg. Twenty-four subjects were considered unevaluable because of compliance issues, including one Malarone subject (with no detectable drug levels) who became infected with P. vivax. Of the 97 evaluable subjects who received Malarone (250 mg atovaquone plus 100 mg proguanil hydrochloride) daily from 1 day before entering the endemic area to 7 days after leaving the endemic area, none became parasitemic. Of the 46 evaluable placebo subjects, 11 became infected with P. vivax and 2 became infected with Plasmodium falciparum. The protective efficacy of Malarone for all malaria and for P. vivax malaria was 100% (LL 95% CI = 63%) and 100% (LL 95% CI = 58%), respectively, and was 96% if the one case with undetectable blood levels was included. Malarone has high protective efficacy for P. vivax in Colombia.
AuthorsJaime Soto, Julia Toledo, Magda Luzz, Patricia Gutierrez, Jonathan Berman, Stephane Duparc
JournalThe American journal of tropical medicine and hygiene (Am J Trop Med Hyg) Vol. 75 Issue 3 Pg. 430-3 (Sep 2006) ISSN: 0002-9637 [Print] United States
PMID16968916 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Antimalarials
  • Drug Combinations
  • Naphthoquinones
  • Placebos
  • atovaquone, proguanil drug combination
  • Proguanil
  • Atovaquone
Topics
  • Adolescent
  • Adult
  • Antimalarials (therapeutic use)
  • Atovaquone
  • Colombia
  • Double-Blind Method
  • Drug Combinations
  • Humans
  • Malaria (prevention & control)
  • Male
  • Military Personnel
  • Naphthoquinones (therapeutic use)
  • Placebos
  • Proguanil (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: